Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Neharika Jain

Earnings Preview: What to Expect From Johnson & Johnson's Report

Headquartered in New Brunswick, New Jersey, Johnson & Johnson (JNJ) researches and develops, manufactures, and sells various products in the healthcare field. Valued at a market cap of $385.1 billion, the company boasts a broad portfolio of drugs covering a wide range of areas such as neuroscience, cardiovascular & metabolism, immunology, oncology, pulmonary hypertension and infectious diseases and vaccines. It is expected to announce its fiscal Q1 earnings for 2025 before the market opens on Tuesday, Apr. 15.

Prior to this event, analysts project this healthcare giant to report a profit of $2.59 per share, down 4.4% from $2.71 per share in the year-ago quarter. The company has exceeded Wall Street's earnings estimates in each of the last four quarters. Its earnings of $2.04 per share in the previous quarter outpaced the consensus estimate by 2%.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.